His primary areas of study are Genetics, Gene expression, Computational biology, Cancer and Gene. His work on Carcinogenesis, Gene identifier and Exome as part of general Genetics study is frequently linked to Vemurafenib and Ingenuity, bridging the gap between disciplines. His Gene expression study integrates concerns from other disciplines, such as Cancer cell, Cell culture, Gene silencing and Central nervous system.
His studies in Computational biology integrate themes in fields like Regulation of gene expression, Messenger RNA, Bioinformatics and Genomics. The study incorporates disciplines such as Mutation, Exome sequencing, Systems pharmacology and Pharmacogenomics in addition to Cancer. His Gene study deals with Molecular biology intersecting with Gene expression profiling.
His primary scientific interests are in Genetics, Gene, Molecular biology, Cancer and Computational biology. His research on Gene frequently links to adjacent areas such as Drug. His research investigates the link between Molecular biology and topics such as DNA that cross with problems in Virology and Genome.
William C. Reinhold has included themes like Transcriptome, Cancer research, Mutation and DNA methylation in his Cancer study. His Computational biology research focuses on Genomics and how it relates to Pharmacogenomics. William C. Reinhold has researched Gene expression profiling in several fields, including Microarray and Proteomics.
His scientific interests lie mostly in Computational biology, Genomics, Cancer, Gene and DNA methylation. His research in Computational biology focuses on subjects like Cancer cell lines, which are connected to Drug activity. His Cancer research includes elements of Cancer research and Pharmacogenomics.
His research in Gene intersects with topics in Drug and Cell biology. His work in the fields of Gene expression profiling and Gene signature overlaps with other areas such as POLD1. His Gene expression profiling research is multidisciplinary, incorporating perspectives in Regulation of gene expression and RNA splicing.
William C. Reinhold spends much of his time researching Genomics, Gene, DNA methylation, Computational biology and Cancer systems biology. His studies deal with areas such as Transcriptome, ASCL1, Transcription factor, YAP1 and PI3K/AKT/mTOR pathway as well as Genomics. William C. Reinhold combines topics linked to Mitosis with his work on Gene.
His DNA methylation research includes themes of Aurora kinase, Methylation, EZH2 and Notch signaling pathway. His biological study spans a wide range of topics, including Proteome, Gene expression, Gene expression profiling, RNA and DNA replication. His Cancer systems biology study combines topics in areas such as Mi-2/NuRD complex, Chromatin remodeling, Proteomics and Cancer cell lines.
A gene expression database for the molecular pharmacology of cancer
Uwe Scherf;Douglas T. Ross;Mark Waltham;Lawrence H. Smith.
Nature Genetics (2000)
GoMiner: a resource for biological interpretation of genomic and proteomic data
Barry R Zeeberg;Weimin Feng;Geoffrey Wang;May D Wang.
Genome Biology (2003)
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
R A Berkman;M J Merrill;W C Reinhold;W T Monacci.
Journal of Clinical Investigation (1993)
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells
Gergely Szakács;Jean Philippe Annereau;Samir Lababidi;Uma Shankavaram.
Cancer Cell (2004)
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
Satoshi Nishizuka;Lu Charboneau;Lynn Young;Sylvia Major.
Proceedings of the National Academy of Sciences of the United States of America (2003)
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set
William C. Reinhold;Margot Sunshine;Margot Sunshine;Hongfang Liu;Sudhir Varma.
Cancer Research (2012)
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.
Ogechi N. Ikediobi;Helen Davies;Graham Bignell;Sarah Edkins.
Molecular Cancer Therapeutics (2006)
MicroRNAs modulate the chemosensitivity of tumor cells
Paul E. Blower;Ji Hyun Chung;Joseph S. Verducci;Shili Lin.
Molecular Cancer Therapeutics (2008)
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study
Uma T. Shankavaram;William C. Reinhold;Satoshi Nishizuka;Sylvia Major.
Molecular Cancer Therapeutics (2007)
Membrane Transporters and Channels: Role of the Transportome in Cancer Chemosensitivity and Chemoresistance
Ying Huang;Pascale Anderle;Kimberly J. Bussey;Catalin Barbacioru.
Cancer Research (2004)
If you think any of the details on this page are incorrect, let us know.